Data as of Nov 21
| -0.50 / -4.02%|
The 7 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 21.00, with a high estimate of 31.00 and a low estimate of 13.00. The median estimate represents a +76.03% increase from the last price of 11.93.
The current consensus among 7 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.